@article{cf9a31c1b6ee4123ad640d5fcb76a2e4,
title = "Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma",
keywords = "Anaplastic large cell lymphoma, Anaplastic lymphoma kinase, CD30, Epithelioid inflammatory myofibroblastic sarcoma, Inflammatory myofibroblastic tumor",
author = "Amr Fadl and Feldman, {Andrew L.}",
note = "Funding Information: This study was supporting in part by funding from the National Cancer Institute (grant number P01 CA229100; Andrew L. Feldman). Andrew L. Feldman has received research funding from Seattle Genetics, is an inventor of technology for which Mayo Clinic holds unlicensed patents, and has received royalties for intellectual property licensed to Zeno Pharmaceuticals. ",
year = "2023",
month = jun,
doi = "10.1007/s12308-023-00537-8",
language = "English (US)",
volume = "16",
pages = "125--126",
journal = "Journal of Hematopathology",
issn = "1868-9256",
publisher = "Springer Verlag",
number = "2",
}